Analyst Consensus ?
ConsensusBuy21 ratings
Bullish1571.4%
Neutral628.6%
Bearish00.0%
CRH plc · CRH · FY2026 Q2 · Calendar Q3 2026
CRH Q2: Record quarter, guidance maintained amid M&A expansion
The supplied analysis supports a constructive but conditional view: CRH's infrastructure exposure, acquisition pipeline and reported margin expansion strengthen the growth case, while guidance execution, integration and cost pressures remain central tests.
Reported Before market openNYSEBasic Materials
$58.23B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.21
Consensus $2.02
EPS surprise
+9.4%
Reported versus consensus
Reported revenue
$10.78B
Consensus $10.68B
Revenue surprise
+0.9%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-3.7%
Event window
SPY move
+1.7%
Same window
Abnormal move
-5.4%
Stock minus SPY
Volume
1.5×
Versus trailing sessions
Subsequent drift
-0.4%
Up to 20 sessions
CRHSPY benchmark
Ask FN2 about CRH FY2026 Q2
Transcript, numbers and history already loaded
Why did CRH fall 3.7% after beating EPS estimates in FY2026 Q2?What changed in CRH's guidance and outlook in FY2026 Q2?Give me the bull and bear case for CRH after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
CRH shifted from the prior quarter's announced portfolio actions and reaffirmed outlook to a record Q2 with continued margin expansion, a pending $8.5 billion Arcosa acquisition, $800 million of growth capex and a pause in share buybacks pending integration.
Guidance delta
Management reaffirmed 2026 adjusted EBITDA, net income and EPS guidance; no change was identified in the supplied analysis.
Key takeaways
- Management described a record Q2 with revenue and adjusted EBITDA growth and margin expansion despite inflationary pressure.
- The call emphasized infrastructure, data-center and reindustrialization demand, alongside water, roads, aggregates and cement platforms.
- The $8.5 billion Arcosa transaction and $800 million growth-capex program increase the execution focus.
- Demand and pricing commentary was constructive, but Building Solutions margins, asphalt profitability and residential volumes remain watchpoints.
Management priorities
- Complete the Arcosa acquisition subject to shareholder and regulatory approvals.
- Pursue growth capex for capacity, automation and energy efficiency.
- Continue acquisition activity in high-growth, fragmented markets.
- Expand market teams focused on data centers and other megatrend projects.
- Integrate acquisitions and pursue targeted synergies.
Follow CRH with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$87.06Current
$88Low
$128.04Average
$165.6High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Sep 9, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 31, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Jefferies | Buy | Buy | Maintain | Jun 26, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Mar 3, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Mar 2, 2026 |
| UBS | Buy | Buy | Maintain | Jan 8, 2026 |
| Citigroup | Buy | Buy | Maintain | Jan 8, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Nov 12, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Nov 7, 2025 |
| Barclays | Overweight | Overweight | Maintain | Oct 20, 2025 |
| Bernstein | Outperform | Outperform | Maintain | Sep 11, 2025 |
| Stifel | Hold | Buy | Downgrade | Apr 15, 2024 |
| Redburn Partners | Buy | Neutral | Upgrade | Jan 3, 2023 |
| Berenberg | Hold | Hold | Maintain | Jan 14, 2021 |
| Canaccord Genuity | Buy | Hold | Upgrade | Nov 2, 2016 |
| Societe Generale | Hold | Buy | Downgrade | Aug 26, 2016 |
| Bank of America | Neutral | Underperform | Upgrade | Apr 25, 2016 |
| B of A Securities | Neutral | Underperform | Upgrade | Apr 24, 2016 |
| HSBC | Buy | Hold | Upgrade | Jan 27, 2016 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jan 15, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $87.06. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $107 | $90.61 | +22.9% | Sep 9, 2026 |
| Berenberg Bank | Harry Goad | $140 | $92.24 | +60.8% | Sep 8, 2026 |
| D.A. Davidson | Garik Shmois | $137 | $95.79 | +57.4% | Aug 24, 2026 |
| Stephens | Analyst unavailable | $125 | $96 | +43.6% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $132 | $106.21 | +51.6% | Jul 8, 2026 |
| Jefferies | Analyst unavailable | $165.6 | $113.05 | +90.2% | Jun 26, 2026 |
| Morgan Stanley | Angel Castillo | $139 | $116.19 | +59.7% | Apr 15, 2026 |
| D.A. Davidson | Analyst unavailable | $120 | $125.17 | +37.8% | Feb 20, 2026 |
| Wells Fargo | Analyst unavailable | $133 | $122.46 | +52.8% | Jan 29, 2026 |
| Wells Fargo | Analyst unavailable | $138 | $131.38 | +58.5% | Jan 13, 2026 |
| UBS | Analyst unavailable | $147 | $122.76 | +68.8% | Jan 8, 2026 |
| Morgan Stanley | Angel Castillo | $140 | $123.68 | +60.8% | Dec 10, 2025 |
| Deutsche Bank | Analyst unavailable | $139 | $119.49 | +59.7% | Dec 8, 2025 |
| Barclays | Adam Seiden | $131 | $117.46 | +50.5% | Oct 20, 2025 |
| UBS | Julian Radlinger | $138 | $117.54 | +58.5% | Oct 14, 2025 |
| Morgan Stanley | Analyst unavailable | $134 | $117.85 | +53.9% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $135 | $116.34 | +55.1% | Oct 7, 2025 |
| UBS | Analyst unavailable | $140 | $121.1 | +60.8% | Oct 2, 2025 |
| UBS | Analyst unavailable | $152 | $119.9 | +74.6% | Oct 1, 2025 |
| RBC Capital | Anthony Codling | $108 | $85.78 | +24.0% | Apr 14, 2025 |
| Berenberg Bank | Analyst unavailable | $120 | $102.52 | +37.8% | Feb 28, 2025 |
| Truist Financial | Keith Hughes | $110 | $82.79 | +26.3% | Aug 9, 2024 |
| Morgan Stanley | Cedar Ekblom | $88 | $74.23 | +1.1% | Jul 9, 2024 |
| Truist Financial | Keith Hughes | $100 | $83.44 | +14.9% | May 13, 2024 |
| Truist Financial | Keith Hughes | $81 | $67.5 | -7.0% | Dec 14, 2023 |
Track every rating change on CRH the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCRH plc, together with its subsidiaries, provides building materials solutions in Ireland, the United States, the United Kingdom, rest of Europe, and internationally. It operates through three segments: Americas Materials Solutions, Americas Building Solutions, and International Solutions. The company offers building materials for the construction and maintenance of public infrastructure, and commercial and residential buildings, as well as construction and renovation of transportation infrastructure, critical utility networks, commercial and residential buildings, and outdoor living spaces; paving and construction services; and produces and sells aggregates, cementitious materials, ready mixed concrete and mortars, and asphalt.…
Historical context
All CRH earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| HMY Harmony Gold Mining Company Limited | FY2026 Q4 · Calendar Q3 2026 | 0.0% | -6.2% | Harmony Gold posts record FY2026 while Eva Copper risks remain |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the CRH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-06T17:15:00.372661+00:00
- FN2 earnings calendar · 2026-09-04T01:23:15.205020+00:00
- Polygon adjusted daily market bars · 2026-09-22T13:50:52.250738+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-22T13:50:52.247914+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-22. For educational purposes only; not investment advice.